SynAct Pharma AB (STO: SYNACT)
Sweden
· Delayed Price · Currency is SEK 8.81
-0.19 (-2.11%)
Nov 18, 2024, 12:14 PM CET
SynAct Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 38.49 | 62.4 | 108.25 | 24 | 14.55 | 3.51 | Upgrade
|
| Cash & Short-Term Investments | 38.49 | 62.4 | 108.25 | 24 | 14.55 | 3.51 | Upgrade
|
| Cash Growth | 33.29% | -42.36% | 351.08% | 64.95% | 315.06% | -50.40% | Upgrade
|
| Other Receivables | 17.51 | 12.41 | 14.7 | 10.67 | 6.46 | 21.95 | Upgrade
|
| Receivables | 17.51 | 12.41 | 14.7 | 10.67 | 6.46 | 21.95 | Upgrade
|
| Prepaid Expenses | 7.54 | 0.26 | 17.29 | 0.25 | 0.32 | 0.28 | Upgrade
|
| Other Current Assets | - | -0 | -0 | 0 | - | - | Upgrade
|
| Total Current Assets | 63.53 | 75.06 | 140.23 | 34.92 | 21.33 | 25.73 | Upgrade
|
| Property, Plant & Equipment | 1.44 | 0.66 | 2.1 | 3.18 | - | - | Upgrade
|
| Long-Term Investments | - | 0.05 | 0.27 | 0.27 | 0.26 | 0.18 | Upgrade
|
| Other Intangible Assets | 152.02 | 152.16 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.14 | 0.09 | - | - | - | - | Upgrade
|
| Total Assets | 217.13 | 228.02 | 142.6 | 38.37 | 21.59 | 25.91 | Upgrade
|
| Accounts Payable | 6.45 | 9.67 | 4.72 | 4.25 | 2.78 | 5.46 | Upgrade
|
| Accrued Expenses | 5.04 | 9.82 | 4.91 | 7.89 | 2.76 | 8.26 | Upgrade
|
| Current Portion of Leases | 0.5 | 0.58 | 1 | 0.98 | - | - | Upgrade
|
| Other Current Liabilities | 4.36 | 4.88 | 4.38 | 2.27 | 0.19 | - | Upgrade
|
| Total Current Liabilities | 16.36 | 24.94 | 15.01 | 15.39 | 5.73 | 13.73 | Upgrade
|
| Long-Term Leases | 0.93 | 0.06 | 1.06 | 2.11 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 18 | 18.02 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 12.68 | 8.82 | - | - | - | - | Upgrade
|
| Total Liabilities | 47.97 | 51.83 | 16.08 | 17.5 | 5.73 | 13.73 | Upgrade
|
| Common Stock | 5.16 | 4.45 | 3.71 | 3.25 | 3.05 | 2.1 | Upgrade
|
| Additional Paid-In Capital | 702.8 | 646.57 | 394.84 | 193.6 | 119.4 | 89.55 | Upgrade
|
| Retained Earnings | -554.62 | -490.6 | -274.79 | -175.59 | -106.28 | -79.73 | Upgrade
|
| Comprehensive Income & Other | 15.82 | 15.77 | 2.77 | -0.4 | -0.3 | 0.27 | Upgrade
|
| Shareholders' Equity | 169.16 | 176.19 | 126.52 | 20.87 | 15.87 | 12.19 | Upgrade
|
| Total Liabilities & Equity | 217.13 | 228.02 | 142.6 | 38.37 | 21.59 | 25.91 | Upgrade
|
| Total Debt | 1.43 | 0.64 | 2.06 | 3.09 | - | - | Upgrade
|
| Net Cash (Debt) | 37.06 | 61.76 | 106.18 | 20.91 | 14.55 | 3.51 | Upgrade
|
| Net Cash Growth | 32.03% | -41.84% | 407.85% | 43.72% | 315.06% | -50.40% | Upgrade
|
| Net Cash Per Share | 0.98 | 1.90 | 3.85 | 0.81 | 0.68 | 0.23 | Upgrade
|
| Filing Date Shares Outstanding | 41.3 | 35.57 | 31.82 | 26.01 | 24.41 | 19.57 | Upgrade
|
| Total Common Shares Outstanding | 41.3 | 35.57 | 29.65 | 26.01 | 24.41 | 19.57 | Upgrade
|
| Working Capital | 47.18 | 50.12 | 125.22 | 19.53 | 15.6 | 12.01 | Upgrade
|
| Book Value Per Share | 4.10 | 4.95 | 4.27 | 0.80 | 0.65 | 0.62 | Upgrade
|
| Tangible Book Value | 17.15 | 24.03 | 126.52 | 20.87 | 15.87 | 12.19 | Upgrade
|
| Tangible Book Value Per Share | 0.42 | 0.68 | 4.27 | 0.80 | 0.65 | 0.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.